Iris Technologies: New Study Supports Non-LCD E-Paper Technology

Ontario Industry Updates
Written By Guest User

A new study conducted by the Canadian Concussion Centre and Dr. Charles Tator has shown that Iris Technologies' Non-LCD E-Paper Technology can decrease the risk of exacerbating symptoms in sufferers of post-concussion syndrome (PCS).

The study's findings provide a potential option for earlier return to work or return to school for light sensitivity and computer or cell phone screen intolerance sufferers.

Founded by Colin Harding and Conor Ross, Iris Technologies' patent-pending, research backed, E-paper secondary monitor to reduce the negative health repercussions of using LCD screens for individuals recovering from a concussion

To read more about Iris Technologies - an OBIO Pre-CAAP 2017 company - and UHN's press release about the study, click here.

Guest User
Previous

OBIO Companies Advance to Semi-Finals of 2017 Interface Health Challenge X
Next

US FDA launches Digital Health Innovation Action Plan & Pre-Certification Software Pilot Program